Ignite Creation Date:
2024-05-05 @ 4:46 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00310388
Status:
TERMINATED
Last Update Posted:
2018-11-15
First Post:
2006-03-30
Brief Title:
Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial 115097
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-07-05
Start Date Type:
ACTUAL
Primary Completion Date:
2017-04-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-05-24
Completion Date Type:
ACTUAL
First Submit Date:
2006-03-30
First Submit QC Date:
March 30 2006
Study First Post Date:
2006-04-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-06-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-16
Last Update Post Date:
2018-11-15
Last Update Post Date Type:
ACTUAL